---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015220"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T19:32:23.089413+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Calidi amends $1.5M convertible note to allow payoff via registered offering participation

## Summary
- On April 14, 2024, amended a $1.5M convertible note issued to settle an unasserted claim.
- If holder participates in a registered public offering on same terms as others, proceeds from its sale will repay the note.
- Amendment incorporated by reference to Exhibit 10.51 of Form S-1 (No. 333-276741) filed April 15, 2024.

## SEC filing metadata
- accession: 0001493152-24-015220
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/0001493152-24-015220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015220
- JSON: https://secwatch.observer/filing/0001493152-24-015220.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015220.txt

## Key facts
- Material Agreements
  Calidi Biotherapeutics, Inc. amended Amendment to Convertible Note and Settlement Agreement with an investor valued at $1.5 million convertible note (effective 2024-04-14).
  - Action: amendment
  - Agreement: settlement
  - Counterparty: an investor
  - Value: $1.5 million convertible note
  - Effective: 2024-04-14
  source text: On April 14, 2024, the Company amended the Note to provide that if the holder thereof participates in a registered public offering, under the same terms and conditions as other investors, in the amount equal to the principal amount of the Note, the proceeds from the sale of securities to the promissory noteholder would be used to pay off the Note.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/0001493152-24-015220-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.